Clinical Trial Update: Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo. [Phase 1]

View source ↗

Summary

A Phase 1 single-dose crossover study comparing respiratory drive effects of Belbuca, oxycodone, and placebo; results completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Depression

Drugs mentioned

• BELBUCA (Buprenorphine hydrochloride)
• Oxycodone (oxycodone)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Respiratory Depression | Phase 1 | Status: COMPLETED | Results posted: 2021-02-05